Skip to main content

Table 4 Follow-up clinical characteristics

From: Adherence therapy for adults with type 2 diabetes: a feasibility study of a randomized controlled trial

Characteristics

AT group

N = 5

TAU group

N = 3

All participants

N = 8

Duration of diabetes in years

 Median

6

3

5.5

 Range

2–20

2–12

2–20

HbA1c, n (%)

n = 2

n = 2

n = 4

 Normal

1 (50)

2 (100)

3 (75)

 Abnormal

1 (50)

0 (0)

1 (25)

Medication measures, Mean (SD)

n = 5

n = 3

n = 8

 MARS-5

19.60 (3.91)

22.33 (0.58)

20.63 (3.29)

 BMQ-General

37.20 (6.87)

39.33 (4.62)

38.00 (5.86)

Diabetes complications, n (%)

n = 5

n = 3

n = 8

 Yes

0 (0)

1 (33)

1 (13)

 No

5 (100)

2 (67)

12 (87)

Comorbidity, n (%)

 Yes

4 (80)

2 (67)

6 (75)

 No

1 (20)

1 (33)

2 (25)